Biovie BIVI
NASDAQ BIVI
$1.95 +0.09 (+4.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biovie (BIVI) Preferred Dividend Payments (2018 - 2021)

Biovie (BIVI) posted Preferred Dividend Payments of $53.6 million for Q3 2021, little changed sequentially from $53.6 million in Q3 2020, and little changed YoY from $53.6 million in Q3 2020.

Biovie (BIVI) Preferred Dividend Payments (2018 - 2021) Analysis & Trends

Biovie has reported Preferred Dividend Payments for 4 years, with the latest figure at $53.6 million in Q3 2021.

  • Quarterly Preferred Dividend Payments changed 0.0% year-over-year to $53.6 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $53.6 million (changed 0.0% YoY) and the FY2021 annual result came in at $53.6 million, up 213.46% from the prior year.
  • Preferred Dividend Payments held at $53.6 million in Q3 2021 per BIVI's latest filing, from $53.6 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $53.6 million in Q3 2020 and troughed at $48659.0 in Q3 2018.
  • A 4-year average of $31.1 million and a median of $35.3 million in 2019 frame the typical range for Preferred Dividend Payments.
  • The sharpest annual moves came in 2019 and 2021: Preferred Dividend Payments jumped 35040.59% in 2019, then changed 0.0% in 2021.
  • Over 4 years, Preferred Dividend Payments stood at $48659.0 in 2018, then surged by 35040.59% to $17.1 million in 2019, then surged by 213.46% to $53.6 million in 2020, then changed by 0.0% to $53.6 million in 2021.
  • According to Business Quant data, Preferred Dividend Payments over the past three periods registered $53.6 million, $53.6 million, and $17.1 million for Q3 2021, Q3 2020, and Q3 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Biovie 14.17 Mn 14.17 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 53.60 Mn
Sep 30, 2020 53.60 Mn
Sep 30, 2019 17.10 Mn
Sep 30, 2018 48,659.00